Growing Safety Concerns of Healthcare and Nursing Staff Increase the Market Acceptance of Retractable Syringes
Safety issues concerning regular syringes are driving the adoption of retractable syringes across the world. For instance, nearly 5.6 million healthcare workers in the U.S. suffer as many as 800,000 sharps injuries-mostly with needlesticks-each year. At this rate, around 2,100 health care professionals are likely to incur a needlestick-related injury every day. On an average, one out of every seven workers is accidentally struck by a contaminated sharp/needle and only one out of three incidents is reported. Companies participating in the world retractable syringes market are making use of these staggering statistics to convince end users on the advantages of using retractable syringes and thereby, increase their market penetration.
This strategic analysis by Frost & Sullivan studies the global market opportunities for retractable syringes-a segment of safety syringes. The study provides a thorough analysis of latest trends in various product categories that is likely to not only aid companies in aligning their market positioning strategies but also optimize their investment in research and development.
High Costs and Low Awareness among End Users Slow Down Growth
Retractable syringes cost more than a regular syringe. This additional cost along with the lack of proper reimbursement norms are forcing hospitals to refrain from adopting retractable syringes. Moreover, end users and distributors are mostly unaware of the retractable syringe technology. Physicians and nurses continue to follow traditional practices for injecting drugs, further hindering the switch over rates to retractable syringes and ultimately, slowing down market penetration.
Demographic Changes, New Legislation, and Technological Advancements Encourage Market Expansion
The presence of a huge patient base in China and India coupled with the aging of world population, and the corresponding increase in the amount spent on healthcare is likely to increase the demand for retractable syringes in the coming years. Moreover, newer and stricter government regulations are forcing healthcare facilities and physicians to adopt the use of retractable syringes.
Intense competition and growing demand from patients for safer, sophisticated retractable syringes are forcing market participants to spend millions of dollars in developing innovative and high-quality products. However, long-term growth is likely to depend on the ability of manufacturers to bring down production costs and prices.
Frost & Sullivan Growth Partnership Service
Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) program that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behavior and overall company direction. The foundation of Frost & Sullivan's GPS includes:
- Assisting companies to reach their full potential in the core business
- Providing growth strategies to help companies expand into related businesses
- Preemptively redefining the core business during market turbulence
- Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies
- Recommending growth management strategies through continuous partnership
To maximize the potential for growth within a firm's internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan's strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients' growth.